Navigation Links
Endo Pharmaceuticals Reports Second Quarter Revenues and Updates Financial Guidance, Reflecting the Acquisition of American Medical Systems
Date:8/9/2011

Supplemental Financial InformationThe following tables provide a reconciliation of our reported (GAAP) statements of operations to our adjusted statements of operations for each of the three months ended June 30, 2011 and June 30, 2010 (in thousands, except per share data): Three Months Ended June 30, 2011 (unaudited)Actual
Reported
(GAAP)AdjustmentsAdjustedREVENUES

$  607,611

$  —$  607,611COSTS AND EXPENSES: Cost of revenues

236,697

(52,018)

(1)

184,679 Selling, general and administrative

178,133

(954)

(2)

177,179 Research and development

40,840

(4,990)

(3)

35,850 Acquisition-related items

17,626

(17,626)

(4)

—OPERATING INCOME

$  134,315

$  75,588$  209,903INTEREST EXPENSE, NET

25,560

(4,719)

(5)

20,841LOSS ON EXTINGUISHMENT OF DEBT, NET

8,548

(8,548)

(6)

—OTHER INCOME, NET

(125)

—(125)INCOME BEFORE INCOME TAXES

$  100,332

$  88,855$  189,187INCOME TAXES

32,780

14,738

(7)

47,518CONSOLIDATED NET INCOME

$  67,552

$  74,117$  141,669Less: Net income attributable to noncontrolling interests

(12,969)

—(12,969)NET INCOME ATTRIBUTABLE TO ENDO PHARMACEUTICALS HOLDINGS INC.

$  54,583

74,117$  128,700DILUTED EARNINGS PER SHARE

$  0.44$  1.05DILUTED WEIGHTED AVERAGE SHARES

122,686122,686Notes to reconciliation of our GAAP statements of operations to our adjusted statements of operations:(1) To exclude amortization of commercial intangible assets related to marketed products of $40,023, the impact of inventory step-up recorded as part of acquisition accounting of $2,995, and milestone payments to partners of $9,000.

(
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 27, 2015  The Academy of Managed Care ... Administration,s (FDA,s) draft guidance and proposed rule that ... to bear a nonproprietary name with an FDA-designated ... a decision from the FDA on the naming ... stakeholders urging the agency to use the same ...
(Date:8/27/2015)... , Aug. 27, 2015  A recent ... KSSTA Knee Journal, compared the Arthrosurface HemiCAP® Wave ... design, versus an "onlay" design implant for isolated ... improvements in function and pain scores, none of ... of osteoarthritis (OA). However, 53% of the patients ...
(Date:8/27/2015)... CUPERTINO, Calif. , Aug. 27, 2015 ... management is scheduled to present at three upcoming healthcare ... , President and CEO, will present at the Rodman ... 10:00 a.m. Eastern time. The conference is being held ... York City . A live audio webcast of ...
Breaking Medicine Technology:AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3DURECT to Participate in Upcoming Healthcare Conferences 2
... ALR ), a global leader in enabling ... through the merger of rapid diagnostics and health management, ... JMP Securities Healthcare Conference being held September 27 through ... Avenue, New York.  Jon Russell, Vice President, Finance, will ...
... ALR ) announced today that, in connection with its ... it entered into a purchase agreement with the initial purchasers ... the offering was increased from $350.0 million to $400.0 million. ... offered at 100.0% of the aggregate principal amount of the ...
Cached Medicine Technology:Alere Inc. Announces Pricing of Senior Subordinated Notes Offering; Offering Size Increased to $400.0 Million 2
(Date:8/28/2015)... ... August 28, 2015 , ... Santa Rosa was recently recognized, for the fourth ... Healthcare. In the KLAS “2015 Midterm Performance Review: Software & Services”, Santa Rosa achieved ... from Modern Healthcare and KLAS are directly related to our company culture.” said Richard ...
(Date:8/27/2015)... ... August 28, 2015 , ... ... out of foster care through “The Language of Flowers,” has joined the Youth ... work, particularly the organization’s YVLifeSet program, was piqued by her passion for helping ...
(Date:8/27/2015)... ... 2015 , ... According to an article published August 21st on ... the success of a patient who is attempting to lose weight. Specifically, the trial ... over that period, and compared those results with how helpful each patient felt their ...
(Date:8/27/2015)... ... August 27, 2015 , ... Workflow ... quantitative PCR (qPCR) in the last decade. New features such as ... costs. On the flipside, where do lab managers, technicians, and researchers find handy ...
(Date:8/27/2015)... , ... August 27, 2015 , ... Thriveology Founders, Dr. ... featured speakers at The Amazing Aging Expo in Denver, Colorado on Saturday, August 29, ... are consistently featured in media outlets as health authorities, and will present a two ...
Breaking Medicine News(10 mins):Health News:Santa Rosa Consulting Recognized by Modern Healthcare as One of the Top 100 Best Places to Work and from KLAS Research with the Highest Rating for Go-Live Support 2Health News:Best-selling Author Vanessa Diffenbaugh Joins Youth Villages National Board of Directors 2Health News:Best-selling Author Vanessa Diffenbaugh Joins Youth Villages National Board of Directors 3Health News:Article on Physician Influence on Weight Loss Highlights the Importance of a Doctor Who Cares, says Dr. Feiz & Associates 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 3Health News:Internationally-renowned Naturopathic Doctor and Chiropractor Team up to Reveal Secrets of Avoiding Disease 2
... SIMI VALLEY, Calif., Oct. 10 Dr. ... maintained that techniques,exist to naturally reduce dependence on ... study published in the Journal of,Human Hypertension has ... chiropractic adjustments to correct,misalignment of the atlas vertebrae ...
... Movement, Takes on New ... Role at Dept. of State, ... Brinker, founder of Susan G. Komen for,the Cure, the world,s largest ... U.S. Department of State. Mrs. Laura Bush,was in attendance for the ...
... visit a worksite in your,community, contact Tim ... tkral@oregonrehabilitation.org , 503-585-3337. For,current photos, contact ... The Oregon Rehabilitation Association (ORA), http://www.oregonrehabilitation.org, ... with disabilities this October with National Disability,Employment ...
... Inc (OTC,Bulletin Board: NNTN) announced today that it,s ... record unaudited sales of $4,439,000 (CDN) and $601,000 ... July, August, and September 2007. Tim,Connolly, CEO of ... record,results for our first full quarter for InterACTIVE ...
... Succeed Antoine, CINCINNATI, Oct. 10, 2007 ... that Richard L. Antoine, global human resources,officer, will ... 39 years of,service. (Photo: http://www.newscom.com/cgi-bin/prnh/20071010/CLW078-a ... http://www.newscom.com/cgi-bin/prnh/20071010/CLW078-b ) In ...
... Yum! Brands Launches Global Campaign to Raise Awareness of ... WASHINGTON, Oct. 10 Friends of the World,Food ... World Hunger,Relief Week, a global consumer campaign that will ... Relief Week is spearheaded,by Yum! Brands, the world,s largest ...
Cached Medicine News:Health News:Lower Blood Pressure Without Drugs 2Health News:Susan G. Komen for the Cure Founder Sworn in as Chief of Protocol 2Health News:Susan G. Komen for the Cure Founder Sworn in as Chief of Protocol 3Health News:Susan G. Komen for the Cure Founder Sworn in as Chief of Protocol 4Health News:Revision: October is National Disability Employment Awareness Month 2Health News:Natural Nutrition Subsidiary Reports Record Third Quarter Revenue and EBITDA 2Health News:Richard L. Antoine to Retire as P&G's Global HR Officer 2Health News:Friends of WFP Welcomes 'World Hunger Relief Week' 2
... Used for temporary internal ... to the bladder. The filiform ... placement. Supplied sterile in peel-open ... CAUTION: Periodic evaluation is advised; ...
The horizontal needle box stores loaded needles according to the implant dosimetry plan. The ergonomic and lightweight design reduces time in the operating room....
The vertical needle holder conveniently positions 20 needles vertically in numbered positions for easy loading....
The Brachytherapy C-arm table is a versatile, adjustable table featuring hand and foot controls, removable sections, an X-ray film tray and grid, accessory rails and standard rail mount knee crutches...
Medicine Products: